Medical practices are one of the best acquisition targets in the lower middle market right now. Most operators walk past them because the word "healthcare" triggers images of regulatory minefields and HIPAA audits. That caution is costing them deals.
Here is what the data shows: physician-owned practices generate predictable, recurring cash flows tied to CPT codes and payer contracts rather than economic cycles. Demand is structurally locked in. And per MGMA's 2024 Physician Compensation and Production data, the average physician owner over 58 has been planning an exit for three-plus years with no clear buyer in sight.
The Silver Tsunami that PE is chasing in dentistry and veterinary medicine has not fully hit general and specialty medical practices yet. Physicians built careers around clinical excellence, not sellable businesses. Most have no broker, no CIM, and no defined exit plan. That is an opportunity.
Who is selling and why it matters
Roughly 40% of practicing physicians in the United States are over 55, per AAMC's 2023 workforce projections. Many own small to mid-sized practices with $800K to $4M in annual revenue. They want to retire. They do not want to sell to a hospital system that will crush their culture. And they do not know how to find a private buyer.
This is the deal sourcing advantage for an ETA operator: direct outreach, physician-to-physician (or veteran-to-physician) credibility, and a value proposition that is not "we will extract maximum value from your patient relationships." It is "we will run this well and honor what you built."
How medical practices are valued
Forget revenue multiples. Medical practices are valued on normalized EBITDA.
The normalization process matters more here than in most acquisitions. Physicians routinely run personal vehicles, family payroll, conference travel, and discretionary compensation through the practice P&L. Strip those out. Then reset physician compensation to fair market value using MGMA or SullivanCotter benchmarks. That compensation reset often moves the normalized EBITDA number dramatically in either direction depending on whether the physician is over- or under-paying himself.
Multiples range from 4x to 15x, per Auxo Capital's 2026 medical practice valuation guide. The spread is wide because the quality of earnings varies enormously. A solo primary care practice heavily dependent on one physician clears at the low end. A multi-provider specialty group with $5M+ normalized EBITDA, distributed revenue across providers, and a strong management layer commands the upper range.
Three factors move the multiple:
- Provider concentration: If 60% of revenue goes out the door when the seller retires, buyers apply a steep discount or structure in a lengthy transition period with earnout protections.
- Payer mix: Government payer concentration above 70% introduces reimbursement risk. A diversified commercial payer mix with no single payer exceeding 30% of revenue is the cleaner asset.
- Specialty: High-demand specialties including orthopedics, dermatology, and ophthalmology attract significantly more buyer attention than primary care. Specialty practices also command premium multiples because of their procedure-driven revenue and higher margins.
The corporate practice of medicine problem
This is the deal structure issue that kills acquisitions without experienced counsel.
Roughly 33 states have corporate practice of medicine (CPOM) prohibitions. Under these laws, a non-physician entity cannot own or directly control a medical practice. An operator buying a practice in California, Texas, or New York cannot simply acquire the practice outright the way you would buy a landscaping company.
The standard solution is a management services organization structure. The operator owns the MSO. A licensed physician (often the seller in transition, a newly recruited partner, or a physician-investor) owns the professional corporation. The MSO provides management, billing, staffing, and operational support under a management services agreement. Revenue flows to the PC, then to the MSO as a management fee.
The CPOM issue also affects how you structure the purchase price allocation. Each entity, the PC and the MSO, requires a separate valuation and consideration allocation. Get this wrong and you have a fraudulent conveyance or an unlicensed practice of medicine problem. Both outcomes are deal-ending.
What due diligence actually looks like in healthcare M&A
Expect 8 to 12 weeks of post-LOI due diligence. Healthcare adds layers that a typical lower-middle-market acquisition does not carry.
The non-negotiable DD items:
- Regulatory compliance review: The Anti-Kickback Statute (AKS) and Stark Law govern physician referral relationships and compensation. Any arrangement that involves paying physicians for referrals, or compensation tied to referral volume, creates significant legal liability that transfers with the acquisition. This is not a minor compliance checkbox.
- Payer contract review: Payer contracts often contain change-of-control provisions that allow termination or renegotiation upon a sale. Confirm which contracts are assignable and whether any material relationships require consent. Losing a major payer contract post-close is a thesis-killing event.
- Billing and coding audit: Request two to three years of claims data and run an internal audit before close. Upcoding, unbundling, or billing errors create recoupment exposure under Medicare and Medicaid. If errors exist, they can be self-disclosed, but they must be identified before you own the liability.
- Licensure and credentialing: Provider licenses, DEA registrations, and payer credentialing must remain current and transferable. Credentialing lags at hospitals and payers can delay revenue for 90 to 180 days post-close if not managed proactively.
Financing a medical practice acquisition
SBA 7(a) loans remain the primary financing tool for practices under $5M in purchase price. Under the SBA's current SOP 50 10 8 (effective June 2025), buyers must inject a minimum 10% equity contribution based on total project costs. A seller note can count toward that injection only on full standby, meaning no principal or interest payments during the loan term, which most sellers reject.
For practices above $5M in enterprise value, the financing stack typically includes senior bank debt, a seller note, and sometimes a private equity co-investor or minority equity partner. Many PE firms in the healthcare services space are actively seeking physician practice platforms, especially in high-demand specialties. Partnering with an institutional capital source at the right time accelerates scale.
The acquisition of a medical practice also qualifies for standard acquisition financing approaches including conventional bank loans and mezzanine debt when the cash flow coverage ratio supports the debt service.
The transition period is where deals succeed or fail
Physician practices are heavily relationship-driven. Patients follow their doctor. Referring physicians follow their trusted colleague. A departure without a managed transition can erode 20 to 40% of revenue within 12 months.
Build a transition agreement with teeth. A typical arrangement requires the seller to remain active clinically for 12 to 24 months post-close with defined patient introduction protocols, referral relationship continuity, and community engagement requirements. Tie a meaningful portion of the purchase consideration to milestone-based earnouts anchored to patient retention and revenue stability.
Find a practice administrator who can run operations independently before the seller departs. Many physician-owned practices have never separated clinical and operational leadership. Creating that structure early protects the earnings you paid for.
The bottom line on buying a medical practice
Medical practice acquisitions reward operators who do the regulatory homework that other buyers skip. The compliance complexity is real. CPOM, AKS, and payer contract provisions are not paperwork, they are deal architecture. Get specialized healthcare M&A counsel before you sign an LOI, not after.
The opportunity is real too. A retiring physician with a profitable, under-managed practice and no succession plan is exactly the seller profile that creates strong acquisition returns. Disciplined due diligence, a clean ownership structure, and a credible transition plan are the differentiators. Same EOD logic applies: identify the actual hazard, neutralize it methodically, do not skip steps.
For a broader framework on finding and qualifying acquisition targets, see the acquisition due diligence checklist that covers the universal evaluation process before you go vertical-specific.
Frequently Asked Questions
What is a typical EBITDA multiple for buying a medical practice?
Multiples generally range from 4x to 15x normalized EBITDA, depending on practice size, specialty, provider concentration, and payer mix. Solo primary care practices at the lower end, multi-provider specialty groups with distributed revenue and management depth at the upper end. The multiple reflects how much of the earnings a buyer believes will survive a change of ownership.
Can a non-physician own a medical practice?
In approximately 33 states with corporate practice of medicine (CPOM) prohibitions, a non-physician entity cannot directly own or control a medical practice. Buyers in those states typically use a management services organization structure where the operator owns the MSO and a licensed physician owns the professional corporation. The MSO provides operational support under a management services agreement.
What financing is available for buying a medical practice?
SBA 7(a) loans are the most common path for practice acquisitions under $5M, requiring a minimum 10% equity injection from the buyer. Above $5M, deals typically use senior bank debt combined with a seller note, and sometimes private equity capital. The practice must generate sufficient cash flow to service the debt after normalizing for market-rate physician compensation.
How long does due diligence take when acquiring a medical practice?
Expect 8 to 12 weeks of post-LOI diligence for a medical practice acquisition. Healthcare adds regulatory layers, including Anti-Kickback Statute review, payer contract analysis, billing and coding audits, and licensure verification, that extend the timeline compared to non-healthcare businesses of similar size.
